Evidence-based medicine and common sense: Practical and ethical issues in clinical trials for osteoporosis

Robert P. Heaney

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

For ethical reasons, testing the efficacy of new treatments for chronic diseases such as osteoporosis has hit a brick wall. Furthermore, existing trial designs, although satisfying requirements for drug registration, typically produce results with limited generalizability. Compounding the problem, these results often serve as the basis for treatment guidelines, which, in turn, are assembled by policy-makers and analysts who often do not understand the biology of the systems concerned. In this perspective, the details of these problems are briefly described and the broad outlines of some solutions suggested.

Original languageEnglish
Pages (from-to)105-110
Number of pages6
JournalFuture Rheumatology
Volume2
Issue number1
DOIs
StatePublished - Feb 2007

Fingerprint

Systems Biology
Evidence-Based Medicine
Administrative Personnel
Ethics
Osteoporosis
Chronic Disease
Clinical Trials
Guidelines
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Rheumatology

Cite this

Evidence-based medicine and common sense : Practical and ethical issues in clinical trials for osteoporosis. / Heaney, Robert P.

In: Future Rheumatology, Vol. 2, No. 1, 02.2007, p. 105-110.

Research output: Contribution to journalArticle

@article{fe4dd11d7a334012b1970a319f641a40,
title = "Evidence-based medicine and common sense: Practical and ethical issues in clinical trials for osteoporosis",
abstract = "For ethical reasons, testing the efficacy of new treatments for chronic diseases such as osteoporosis has hit a brick wall. Furthermore, existing trial designs, although satisfying requirements for drug registration, typically produce results with limited generalizability. Compounding the problem, these results often serve as the basis for treatment guidelines, which, in turn, are assembled by policy-makers and analysts who often do not understand the biology of the systems concerned. In this perspective, the details of these problems are briefly described and the broad outlines of some solutions suggested.",
author = "Heaney, {Robert P.}",
year = "2007",
month = "2",
doi = "10.2217/17460816.2.1.105",
language = "English",
volume = "2",
pages = "105--110",
journal = "Future Rheumatology",
issn = "1758-4272",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Evidence-based medicine and common sense

T2 - Practical and ethical issues in clinical trials for osteoporosis

AU - Heaney, Robert P.

PY - 2007/2

Y1 - 2007/2

N2 - For ethical reasons, testing the efficacy of new treatments for chronic diseases such as osteoporosis has hit a brick wall. Furthermore, existing trial designs, although satisfying requirements for drug registration, typically produce results with limited generalizability. Compounding the problem, these results often serve as the basis for treatment guidelines, which, in turn, are assembled by policy-makers and analysts who often do not understand the biology of the systems concerned. In this perspective, the details of these problems are briefly described and the broad outlines of some solutions suggested.

AB - For ethical reasons, testing the efficacy of new treatments for chronic diseases such as osteoporosis has hit a brick wall. Furthermore, existing trial designs, although satisfying requirements for drug registration, typically produce results with limited generalizability. Compounding the problem, these results often serve as the basis for treatment guidelines, which, in turn, are assembled by policy-makers and analysts who often do not understand the biology of the systems concerned. In this perspective, the details of these problems are briefly described and the broad outlines of some solutions suggested.

UR - http://www.scopus.com/inward/record.url?scp=34249284853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249284853&partnerID=8YFLogxK

U2 - 10.2217/17460816.2.1.105

DO - 10.2217/17460816.2.1.105

M3 - Article

AN - SCOPUS:34249284853

VL - 2

SP - 105

EP - 110

JO - Future Rheumatology

JF - Future Rheumatology

SN - 1758-4272

IS - 1

ER -